mexiletine has been researched along with Cardiomyopathies in 7 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Many of these therapies are older medications being given new roles such as mexiletine for Brugada syndrome and diflunisal for transthyretin amyloid cardiomyopathy." | 4.95 | Therapeutic Strategies Targeting Inherited Cardiomyopathies. ( Tang, WHW; Varian, K, 2017) |
| " Sustained rapid ventricular tachyarrhythmias requiring cardioversion for termination were induced by double right ventricular apical extrastimuli during control, and treatment with disopyramide, quinidine, and fluocortolone." | 3.67 | Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. ( Belhassen, B; Laniado, S; Pines, A, 1989) |
| "Monomorphic sustained ventricular tachycardia (MSVT) was revisited in relation to the electrophysiologic findings and their relation to the drug efficacy." | 2.40 | Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications. ( Aizawa, Y; Tanabe, Y; Yamaura, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varian, K | 1 |
| Tang, WHW | 1 |
| Gao, D | 1 |
| Van Herendael, H | 1 |
| Alshengeiti, L | 1 |
| Dorian, P | 1 |
| Mangat, I | 1 |
| Korley, V | 1 |
| Ahmad, K | 1 |
| Golovchiner, G | 1 |
| Aves, T | 1 |
| Pinter, A | 1 |
| Christie, JM | 1 |
| Valdes, C | 1 |
| Markowsky, SJ | 1 |
| Aizawa, Y | 1 |
| Tanabe, Y | 1 |
| Yamaura, M | 1 |
| Hokamura, Y | 1 |
| Shono, H | 1 |
| Uchida, H | 1 |
| Kimura, Y | 1 |
| Takenaka, S | 1 |
| Fukuda, K | 1 |
| Shima, K | 1 |
| Hamada, T | 1 |
| Yoshimura, M | 1 |
| Belhassen, B | 1 |
| Pines, A | 1 |
| Laniado, S | 1 |
| Kasanuki, H | 1 |
| Onishi, S | 1 |
| Hirosawa, K | 1 |
2 reviews available for mexiletine and Cardiomyopathies
| Article | Year |
|---|---|
Therapeutic Strategies Targeting Inherited Cardiomyopathies.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiomyopathies; Diflunisal; Geneti | 2017 |
Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Electrocardiogra | 1998 |
5 other studies available for mexiletine and Cardiomyopathies
| Article | Year |
|---|---|
Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Cohort Studies | 2013 |
Neurotoxicity of lidocaine combined with mexiletine.
Topics: Administration, Oral; Cardiomyopathies; Drug Therapy, Combination; Humans; Injections, Intravenous; | 1993 |
[A case of cardiac sarcoidosis with various electrocardiographic change].
Topics: Cardiomyopathies; Electrocardiography; Female; Humans; Lung Diseases; Mexiletine; Middle Aged; Pacem | 1989 |
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combina | 1989 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatogra | 1985 |